AllianceBernstein’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-69,300
| Closed | -$1.05M | – | 3354 |
|
|
2022
Q3 | $1.05M | Buy |
69,300
+4,600
| +7% | +$53.5K | ﹤0.01% | 2260 |
|
|
2022
Q2 | $485K | Hold |
64,700
| – | – | ﹤0.01% | 2701 |
|
|
2022
Q1 | $589K | Buy |
64,700
+200
| +0.3% | +$1.54K | ﹤0.01% | 2609 |
|
|
2021
Q4 | $453K | Hold |
64,500
| – | – | ﹤0.01% | 2786 |
|
|
2021
Q3 | $735K | Hold |
64,500
| – | – | ﹤0.01% | 2614 |
|
|
2021
Q2 | $1.03M | Buy |
64,500
+5,400
| +9% | +$92.6K | ﹤0.01% | 2517 |
|
|
2021
Q1 | $1.06M | Sell |
59,100
-7,100
| -11% | -$123K | ﹤0.01% | 2390 |
|
|
2020
Q4 | $894K | Sell |
66,200
-5,000
| -7% | -$60.4K | ﹤0.01% | 2342 |
|
|
2020
Q3 | $838K | Sell |
71,200
-80,200
| -53% | -$977K | ﹤0.01% | 2264 |
|
|
2020
Q2 | $2.23M | Sell |
151,400
-588,844
| -80% | -$8.71M | ﹤0.01% | 1787 |
|
|
2020
Q1 | $9.99M | Buy |
740,244
+78,385
| +12% | +$1.49M | 0.01% | 913 |
|
|
2019
Q4 | $16M | Buy |
661,859
+117,437
| +22% | +$2.43M | 0.01% | 890 |
|
|
2019
Q3 | $10.5M | Sell |
544,422
-41,766
| -7% | -$957K | 0.01% | 1035 |
|
|
2019
Q2 | $17.3M | Sell |
586,188
-8,194
| -1% | -$316K | 0.01% | 842 |
|
|
2019
Q1 | $28.2M | Buy |
594,382
+17,999
| +3% | +$792K | 0.02% | 704 |
|
|
2018
Q4 | $20.8M | Buy |
576,383
+106,047
| +23% | +$4.98M | 0.02% | 747 |
|
|
2018
Q3 | $28.9M | Buy |
470,336
+53,484
| +13% | +$3.44M | 0.02% | 680 |
|
|
2018
Q2 | $28.2M | Sell |
416,852
-19,907
| -5% | -$1.11M | 0.02% | 686 |
|
|
2018
Q1 | $23.7M | Buy |
436,759
+65,683
| +18% | +$3.67M | 0.02% | 717 |
|
|
2017
Q4 | $22.2M | Sell |
371,076
-43,654
| -11% | -$2.65M | 0.02% | 746 |
|
|
2017
Q3 | $20.2M | Buy |
414,730
+37,346
| +10% | +$2.04M | 0.02% | 771 |
|
|
2017
Q2 | $19.8M | Sell |
377,384
-44,258
| -10% | -$2.06M | 0.02% | 757 |
|
|
2017
Q1 | $19.1M | Sell |
421,642
-2,041
| -0.5% | -$91K | 0.02% | 768 |
|
|
2016
Q4 | $16M | Buy |
423,683
+561
| +0.1% | +$21.2K | 0.01% | 803 |
|
|
2016
Q3 | $16M | Sell |
423,122
-199,717
| -32% | -$4.4M | 0.01% | 785 |
|
|
2016
Q2 | $11M | Buy |
622,839
+71,201
| +13% | +$1.15M | 0.01% | 859 |
|
|
2016
Q1 | $6.71M | Buy |
551,638
+25,264
| +5% | +$400K | 0.01% | 947 |
|
|
2015
Q4 | $12.8M | Buy |
526,374
+497,474
| +1,721% | +$11.6M | 0.01% | 813 |
|
|
2015
Q3 | $513K | Buy |
28,900
+5,600
| +24% | +$101K | ﹤0.01% | 2473 |
|
|
2015
Q2 | $411K | Buy |
23,300
+16,600
| +248% | +$304K | ﹤0.01% | 2656 |
|
|
2015
Q1 | $210K | Buy |
6,700
+5,000
| +294% | +$145K | ﹤0.01% | 2810 |
|
|
2014
Q4 | $50K | Sell |
1,700
-1,700
| -50% | -$43.1K | ﹤0.01% | 3108 |
|
|
2014
Q3 | $70K | Hold |
3,400
| – | – | ﹤0.01% | 3031 |
|
|
2014
Q2 | $84K | Buy |
+3,400
| New | +$58.9K | ﹤0.01% | 3042 |
|
AllianceBernstein's AERI Position: Q4 2022 in Review
AllianceBernstein sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 69,300 shares — an estimated $1.05M sold.
AllianceBernstein first reported a position in AERI in Q2 2014 and held it in 34 quarters. The position peaked at $28.9M in Q3 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- AllianceBernstein reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- AllianceBernstein sold 69,300 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.05M.
- AllianceBernstein first reported a position in Aerie Pharmaceuticals in Q2 2014 and held it in 34 quarters.
- AllianceBernstein's Aerie Pharmaceuticals position peaked at $28.9M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.